The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
p53 inhibition by the LANA protein of KSHV protects against cell death
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., & Knowles, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321802 · Cited by 2,818
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Moore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,078
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J., & Ganem, D. (1996) · Nature Medicine · doi:10.1038/nm0896-918 · Cited by 751
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735
Efficient Persistence of Extrachromosomal KSHV DNA Mediated by Latency-Associated Nuclear Antigen
Ballestas, M. E., Chatis, P. A., & Kaye, K. M. (1999) · Science · doi:10.1126/science.284.5414.641 · Cited by 694
Binding and modulation of p53 by p300/CBP coactivators
Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693
Gao, S.-J., Kingsley, L., Hoover, D. R., Spira, T. J., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Parry, P., Chang, Y., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350403 · Cited by 596
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor
Leung, K., & Nabel, G. J. (1988) · Nature · doi:10.1038/333776a0 · Cited by 586
Self-citationSarid, R., Flore, O., Bohenzky, R. A., Chang, Y., & Moore, P. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1005-1012.1998 · Cited by 438
Neipel, F., Albrecht, J. C., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4187-4192.1997 · Cited by 402
Cyclin encoded by KS herpesvirus
Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden-Kent, D., Paterson, H., Weiss, R. A., & Mittnacht, S. (1996) · Nature · doi:10.1038/382410a0 · Cited by 341
Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor
Dobner, T., Horikoshi, N., Rubenwolf, S., & Shenk, T. (1996) · Science · doi:10.1126/science.272.5267.1470 · Cited by 311
Kedes, D. H., Lagunoff, M., Renne, R., & Ganem, D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119804 · Cited by 295
Hottiger, M. O., & Nabel, G. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8252-8256.1998 · Cited by 199
Self-citationHIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator
Felzien, L. K., Woffendin, C., Hottiger, M. O., Subbramanian, R. A., Cohen, É. A., & Nabel, G. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5281 · Cited by 148
Self-citationMutant p53 protein expression interferes with p53-independent apoptotic pathways
Li, R., Sutphin, P. D., Schwartz, D., Matas, D., Almog, N., Wolkowicz, R., Goldfinger, N., Pei, H., Prokocimer, M., & Rotter, V. (1998) · Oncogene · doi:10.1038/sj.onc.1201867 · Cited by 140
Generation of Retroviral Vector for Clinical Studies Using Transient Transfection
Yang, S., Delgado, R. B., Barker, C. S., Yang, Z., Nabel, G. J., King, S. R., Woffendin, C., Xu, L., & Nolan, G. P. (1999) · Human Gene Therapy · doi:10.1089/10430349950019255 · Cited by 123
Self-citationA synergistic increase in potency of a multimerized VP16 transcriptional activation domain.
Emami, K. H., & Carey, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05607.x · Cited by 103
Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV
Moore, P. S., & Chang, Y. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01408-5 · Cited by 97
Cited by
Antman, K., & Chang, Y. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421407 · Cited by 1,023
Kaposi's sarcoma and its associated herpesvirus
Mesri, E. A., Cesarman, E., & Boshoff, C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2888 · Cited by 880
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
BET domain co-regulators in obesity, inflammation and cancer
Belkina, A. C., & Denis, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3256 · Cited by 711
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Mesri, E. A., Feitelson, M. A., & Munger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 650
Metadata
- Authors
- Friborg, J., Kong, W.-P., Hottiger, M. O., & Nabel, G. J.
- Venue
- Nature
- Published
- 1999-12
- Volume
- 402
- Issue
- 6764
- Pages
- 889-894
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1673837423
- Cited by
- 704
- References
- 27
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.